OXF BD 02

CAS No. 1429129-68-9

OXF BD 02( —— )

Catalog No. M33898 CAS No. 1429129-68-9

OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 235 In Stock
10MG 353 In Stock
25MG 655 In Stock
50MG 917 In Stock
100MG 1228 In Stock
200MG Get Quote In Stock
500MG 2474 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    OXF BD 02
  • Note
    Research use only, not for human use.
  • Brief Description
    OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
  • Description
    OXF BD 02 is a selective inhibitor of BRD4(1) (the first bromodomain of BRD4) with IC50value of 382 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Epigenetic Reader Domain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1429129-68-9
  • Formula Weight
    295.33
  • Molecular Formula
    C18H17NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C(C2=CC(C(O)C3=CC=CC=C3)=CC(O)=C2)=C(C)ON1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hewings DS, et al. Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. J Med Chem. 2013 Apr 25;56(8):3217-27. ?
molnova catalog
related products
  • BAZ1A-IN-1

    BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.

  • PBRM1-BD2-IN-7

    PBRM1-BD2-IN-7, a selective and cell-active inhibitor targeting the polybromo-1 (PBRM1) bromodomain, demonstrates inhibitory efficacy against PBRM1-BD2 with an IC50 value of 0.29 μM.

  • 3-methyl-1,2,3,4-tet...

    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .